16-Sept-2026 10:20:13
LORDSMARKExpansion
LORD'S MARK INDUSTRIES : EXPANSION OF SILVASSA FACILITY COMPLETED AHEAD OF SCHEDULE
• Phase I expansion at Silvassa facility completed nearly three months ahead of its December 2026 timeline. • Surgical and orthopaedic product portfolio expanded from 36 to 54 SKUs with 18 new products. • Newly expanded production line scheduled to commence commercial operations from October 11, 2026. • Existing portfolio of 36 SKUs holds US FDA approval; 18 new SKUs are progressing through the US FDA approval process, anticipated by December 2026.
Lords Mark Industries Ltd
Open attachment